Clinical Trial Update: New Triple Therapy in Newly Diagnosed Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial from Sun Yat-sen University evaluating a new triple therapy for newly diagnosed Type 2 diabetes; the study has not yet started recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Sun Yat-sen University | Conditions: Diabetes Mellitus | Phase 3 | Status: NOT_YET_RECRUITING